Progressive loss of endothelial P-selectin expression with increasing malignancy in colorectal cancer

Laboratory Investigation

Volumn 85, Issue 2, 2005, Pages 248-256

  Peeters, Charlotte F J M ^a   Ruers, Theo J M ^a   Westphal, Johan R ^a   De Waal, Robert M W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Colorectal cancer; Endothelial cells; Leukocytes; Liver metastasis; P selectin

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CHLORDANE; PADGEM PROTEIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL ADHESION; CELL INFILTRATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LIVER METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; VASCULAR ENDOTHELIUM;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; P-SELECTIN;

EID: 13444251057     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3700217     Document Type: Article

References (30)

1. Wilmink AB. Overview of the epidemiology of colorectal cancer. Dis Colon Rectum 1997;40:483-493.
2. Di Giorgio A, Botti C, Tocchi A, et al. The influence of tumor lymphocytic infiltration on long term survival of surgically treated colorectal cancer patients. Int Surg 1992;77:256-260.
3. Berghella AM, Pellegrini P, Del Beato T, et al. Prognostic significance of immunological evaluation in colorectal cancer. Cancer Biother Radiopharm 1996;11:355-361.
4. Papamichael D. Prognostic role of angiogenesis in colorectal cancer. Anticancer Res 2001;21:4349-4353.
5. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
6. Nash JR. Macrophages in human tumours: an immunohistochemical study. J Pathol 1982;136:72-83.
7. Kansas GS. Selectins and their ligands: current concepts and controversies. Blood 1996;88:3259-3287.
8. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991;67:1033-1036.
9. Carlos TM. Leukocyte recruitment at sites of tumor: dissonant orchestration. J Leukoc Biol 2001;70:171-184.
10. Tedder TF, Steeber DA, Chen A, et al. The selectins: vascular adhesion molecules. FASEB J 1995;9:866-873.
11. Vestweber D, Blanks JE. Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 1999;79:181-213.
12. Somers WS, Tang J, Shaw GD, et al. Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1. Cell 2000;103:467-479.
13. Nooijen PT, Westphal JR, Eggermont AM, et al. Endothelial P-selectin expression is reduced in advanced primary melanoma and melanoma metastasis. Am J Pathol 1998;152:679-682.
14. Suzuki Y, Ohtani H, Mizoi T, et al. Cell adhesion molecule expression by vascular endothelial cells as an immune/inflammatory reaction in human colon carcinoma. Jpn J Cancer Res 1995;86:585-593.
15. Kuzu I, Bicknell R, Fletcher CD, et al. Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab Invest 1993;69:322-428.
16. Ye C, Kiriyama K, Mistuoka C, et al. Expression of E-selectin on endothelial cells of small veins in human colorectal cancer. Int J Cancer 1995;61:455-460.
17. Renkonen J, Paavonen T, Renkonen R. Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma. Int J Cancer 1997;74:296-300.
18. Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet 1987;1:1303-1306.
19. Scott-Conner CE, Christie DW. Cancer staging using the American Joint Committee on Cancer TNM System. J Am Coll Surg 1995;181:182-188.
20. Takahashi Y, Bucana CD, Cleary KR, et al. p53, vessel count, and vascular endothelial growth factor expression in human colon cancer. Int J Cancer 1998;79:34-38.
21. Kreider JW, Bartlett GL, Butkiewicz BL. Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis. Cancer Metastasis Rev 1984;3:53-74.
22. Hamlin IM. Possible host resistance in carcinoma of the breast: a histological study. Br J Cancer 1968;22:383-401.
23. Black MM, Freeman C, Mork T, et al. Prognostic significance of microscopic structure of gastric carcinomas and their regional lymph nodes. Cancer 1971;27:703-711.
24. Cochran AJ. Histology and prognosis in malignant melanoma. J Pathol 1969;97:459-468.
25. Kim YJ, Borsig L, Varki NM, et al. P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 1998;95:9325-9330.
26. Reynolds JL, Akhter J, Adams WJ, et al. Histamine content in colorectal cancer. Are there sufficient levels of histamine to affect lymphocyte function? Eur J Surg Oncol 1997;23:224-227.
27. Dabbous MK, North SM, Haney L, et al. Effects of mast cell-macrophage interactions on the production of collagenolytic enzymes by metastatic tumor cells and tumor-derived and stromal fibroblasts. Clin Exp Metastasis 1995;13:33-41.
28. Dimitriadou V, Koutsilieris M. Mast cell-tumor cell interactions: for or against tumour growth and metastasis? Anticancer Res 1997;17:1541-1549.
29. Harrison JC, Dean PJ, el Zeky F, et al. Impact of the Crohn's-like lymphoid reaction on staging of right-sided colon cancer: results of multivariate analysis. Hum Pathol 1995;26:31-38.
30. Xiong M, Elson G, Legarda D, et al. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol 1998;153:587-598.